BIDIRECTIONAL EFFECTS OF ENDOGENOUS OPIOID-PEPTIDES ON ENDOTHELIN RELEASE RATES IN PORCINE AORTIC ENDOTHELIAL-CELL CULTURE - MEDIATION BY DELTA-OPIOID RECEPTOR AND OPIOID RECEPTOR ANTAGONIST-INSENSITIVE MECHANISMS
Rm. Arendt et al., BIDIRECTIONAL EFFECTS OF ENDOGENOUS OPIOID-PEPTIDES ON ENDOTHELIN RELEASE RATES IN PORCINE AORTIC ENDOTHELIAL-CELL CULTURE - MEDIATION BY DELTA-OPIOID RECEPTOR AND OPIOID RECEPTOR ANTAGONIST-INSENSITIVE MECHANISMS, The Journal of pharmacology and experimental therapeutics, 272(1), 1995, pp. 1-7
The effects of opioid peptides on immunoreactive endothelin (ir ET) re
lease from cultured porcine aortic endothelial cells over a 1-hr perio
d (4-5 or 23-24 hr) were determined by radioimmunoassay and high-perfo
rmance liquid chromatography after treatment for either 4 or 23 hr. En
dogenous opioids, the synthetic delta opioid [D-Pen(2,5)]enkephalin an
d, for comparison, atrial and brain natriuretic peptides were added to
the culture medium in concentrations ranging from 10(-12) to 10(-7) M
. Thrombin (0.1-10 U/ml) served as a stimulatory reference, 1) Brain n
atriuretic peptide displayed only insignificant effects on ir ET relea
se at 5 hr, but strongly inhibited ir ET release at 24 hr. 2) Opioids
modulated release rates at 5 hr but did not display significant effect
s at 24 hr: metorphamide with predominant mulkappa and weak delta opio
id receptor activity stimulated release in a dose-dependent manner, wh
ereas [Met(5)]enkephalin-Arg(6)-Phe(7) with mu/delta activity and the
delta agonists [Leu(5)]enkephalin, sulfated [Leu(5)]enkephalin and [D-
Pen(2,5)]enkephalin decreased release rates; [Leu(5)]enkephalin was th
e most potent of the latter drugs. 3) Coincubation with either the non
selective opioid receptor antagonist naloxone (10(-5) M) or the delta
receptor-selective antagonist ICI-174,864 (N,N-bisallyl-Tyr-D-Ala-Ala-
Aib-Phe-Leu-OH) (10(-5) M) abolished all opioid-induced inhibitory eff
ects, but rather potentiated or unmasked stimulatory effects of opioid
peptides on ir ET release rates at 5 hr and also at 24 hr in the case
of the delta agonists, 4) Naloxone (10(-5) M) potentiated the mild st
imulatory effects of brain natriuretic peptide on ir ET release rate a
t 5 hr and completely reversed its inhibitory effects at 24 hr. In con
clusion, inhibitory effects of opioids on ir ET release appear to be m
ediated by delta opioid receptors, whereas their stimulatory effects i
n the presence of naloxone or ICI-174,864 are not mediated by classica
l (i.e., naloxone-sensitive) opioid receptors. These results suggest a
previously unknown humoral pathway regulating peripheral ET release.